Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2009
Aspirin and other NSAIDs, such as ibuprofen, have been found in preclinical in vitro, in vivo, and epidemiologic studies to have potential utility in breast and colon cancer risk reduction by several mechanisms.1 These mechanisms include inhibition of COX-2, cell proliferation, angiogenesis, and metastasis and induction of apoptosis.2 However, for breast cancer chemoprevention (cancer risk reduction), COX-2 inhibition may specifically decrease prostaglandin induction of aromatase, the enzyme responsible for converting androgens to estrogen in breast tissue.3 Aspirin and other NSAIDs may, therefore, reduce risk of ER+ breast cancer, as suggested by epidemiologic observational data to date, but not ER− breast cancer.4
Kakarala M, Brenner DE. Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study II—Invited Commentary. Arch Intern Med. 2009;169(2):121. doi:10.1001/archinternmed.2008.515
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: